GenMark Diagnostics, Inc
GNMK
GNMK was delisted on the 21st of April, 2021.
78 hedge funds and large institutions have $407M invested in GenMark Diagnostics, Inc in 2014 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 35 increasing their positions, 21 reducing their positions, and 8 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 21
25% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 8
4.11% more ownership
Funds ownership: 93.64% → 97.75% (+4.1%)
0% more funds holding
Funds holding: 78 → 78 (0)
22% less capital invested
Capital invested by funds: $522M → $407M (-$115M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$10.3M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$5.41M |
| 3 |
Millennium Management
New York
|
+$3.63M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$3.13M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$2.78M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
PointState Capital
New York
|
-$3.97M |
| 2 |
Schroder Investment Management Group
London,
United Kingdom
|
-$3.93M |
| 3 |
MACM
March Altus Capital Management
Greenwich,
Connecticut
|
-$2.98M |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$2.92M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$2.52M |
GNMK Hedge Fund Activity: Q1 2014 in Review
78 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q1 2014, worth a combined $407M — down 22% from $522M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new GNMK positions and 8 closed out — a net gain of 2 holders — while 35 added to existing stakes and 21 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $10.3M. The largest seller was PointState Capital, exiting entirely with an estimated $3.97M sold.
- 78 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q1 2014, unchanged from Q4 2013.
- Funds reported $407M of GenMark Diagnostics, Inc stock for Q1 2014, down 22% quarter-over-quarter.
- 10 funds opened new GenMark Diagnostics, Inc positions in Q1 2014 and 8 closed out, a net change of +2 holders.
- The largest GenMark Diagnostics, Inc buyer in Q1 2014 was JP Morgan Chase, an estimated $10.3M added.
- The largest GenMark Diagnostics, Inc seller in Q1 2014 was PointState Capital, an estimated $3.97M sold.
Based on aggregated 13F filings for Q1 2014.